An active researcher, Dr. Odenike is involved in the development of novel therapeutic agents for the treatment of acute and chronic leukemias and chronic myeloproliferative diseases. The ultimate goal of her research is to improve treatment options for patients with these diseases. Dr. Odenike is the principal investigator on a number of clinical trials investigating molecularly targeted agents in this patient population. These clinical trials also integrate laboratory studies to evaluate the effect that these agents have on cancer cells.
UChicago Comprehensive Cancer Center:
Duchossois Center for Advanced Medicine DCAM, 5758 S Maryland Ave, Chicago, IL 60637, USA
Get the latest thought leadership on MDS delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for MDS Newsletter" for MDS news, life
MDS stories, MDS clinical trials, MDS 101 articles and events with MDS